Precigen Appoints Harry Thomasian Jr. as Chief Financial Officer

GERMANTOWN, Md., Oct. 12, 2021 /PRNewswire/ — Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the appointment of Harry Thomasian Jr. as the Company’s chief…

About the Author

has written 41562 stories on this site.

Copyright © 2010 Business and Corporate News.